These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2958957)

  • 1. Involvement of the COOH-terminal portion of the alpha-chain of fibrin in the branching of fibers to form a clot.
    Weisel JW; Papsun DM
    Thromb Res; 1987 Jul; 47(2):155-63. PubMed ID: 2958957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the alpha C domains of fibrin in clot formation.
    Gorkun OV; Veklich YI; Medved LV; Henschen AH; Weisel JW
    Biochemistry; 1994 Jun; 33(22):6986-97. PubMed ID: 8204632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).
    Mosesson MW; Siebenlist KR; DiOrio JP; Matsuda M; Hainfeld JF; Wall JS
    J Clin Invest; 1995 Aug; 96(2):1053-8. PubMed ID: 7635941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of peptides cleaved by plasmin from the C-terminal polymerization domain of human fibrinogen.
    Southan C; Thompson E; Panico M; Etienne T; Morris HR; Lane DA
    J Biol Chem; 1985 Oct; 260(24):13095-101. PubMed ID: 2932434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmic degradation of fibrinogen Paris I.
    Budzynski AZ; Marder VJ
    J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that fibrinogen γ' directly interferes with protofibril growth: implications for fibrin structure and clot stiffness.
    Allan P; Uitte de Willige S; Abou-Saleh RH; Connell SD; Ariëns RA
    J Thromb Haemost; 2012 Jun; 10(6):1072-80. PubMed ID: 22463367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of assays for the detection of fibrin(ogen)olysis based on COOH-terminal A alpha chain epitopes.
    Sobel JH; Wu HQ; Canfield RE
    Blood; 1994 Jul; 84(2):535-46. PubMed ID: 7517717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unique proteolytic fragment of human fibrinogen containing the A alpha COOH-terminal domain of the native molecule.
    Kirschbaum NE; Budzynski AZ
    J Biol Chem; 1990 Aug; 265(23):13669-76. PubMed ID: 2143188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structure and biological features of fibrinogen and fibrin.
    Mosesson MW; Siebenlist KR; Meh DA
    Ann N Y Acad Sci; 2001; 936():11-30. PubMed ID: 11460466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen degradation by hementin, a fibrinogenolytic anticoagulant from the salivary glands of the leech Haementeria ghilianii.
    Malinconico SM; Katz JB; Budzynski AZ
    J Lab Clin Med; 1984 Nov; 104(5):842-54. PubMed ID: 6387015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of primary polymerization sites in the D domain of human fibrinogen depends on intact conformation.
    Cierniewski CS; Kloczewiak M; Budzynski AZ
    J Biol Chem; 1986 Jul; 261(20):9116-21. PubMed ID: 3722190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers.
    Langer BG; Weisel JW; Dinauer PA; Nagaswami C; Bell WR
    J Biol Chem; 1988 Oct; 263(29):15056-63. PubMed ID: 3170575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of bound thrombin consisting of thrombin and fibrin N-terminal fragment from clot lysate.
    Kinjoh K; Nakamura M; Sunagawa M; Kosugi T
    Haematologia (Budap); 2002; 32(4):457-65. PubMed ID: 12803119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of soluble polymerized fibrin formed in the presence of excess fibrinogen fragment D.
    Knoll D; Hantgan R; Williams J; McDonagh J; Hermans J
    Biochemistry; 1984 Jul; 23(16):3708-15. PubMed ID: 6236846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond.
    Bini A; Itoh Y; Kudryk BJ; Nagase H
    Biochemistry; 1996 Oct; 35(40):13056-63. PubMed ID: 8855941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dissolution of human cross-linked plasma fibrin clots by the equimolar human plasmin-derived light (B) chain-streptokinase complex. The acceleration of clot lysis by pretreatment of fibrin clots with the light (B) chain.
    Summaria L; Boreisha IG; Arzadon L; Robbins KC
    Thromb Res; 1977 Sep; 11(3):377-89. PubMed ID: 144332
    [No Abstract]   [Full Text] [Related]  

  • 18. The release of B beta 1-42 from fibrinogen and fibrin by plasmin.
    Hurlet-Jensen A; Koehn JA; Nossel HL
    Thromb Res; 1983 Mar; 29(6):609-17. PubMed ID: 6222508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [alphaC domains of fibrinogen molecules as the structures accelerating fibrin assembly].
    Medved' LV; Gorkun OV; Maniakov VF; Belitser VA
    Mol Biol (Mosk); 1986; 20(2):461-70. PubMed ID: 3702870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.